Leaflet LEFLUNOMIDE WINTHROP 20mg film-coated tablets

Product code:
W55461001
Quantity:
30
Indicated for:
rheumatoid arthritis
Route of administration:
oral
Substance:
leflunomide (immunomodulator)
ATC
L04AA13 — Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants

Precautions:

Avoid live vaccines

Avoid live vaccines during treatment if contraindicated.

Hepatotoxicity

This medicine may affect the liver.

Immunosuppression / infection risk

This medicine may increase the risk of infections.

Leflunomide is a medication used for the treatment of rheumatoid arthritis and psoriatic arthritis. It works by inhibiting pyrimidine synthesis, thereby reducing inflammation and autoimmune responses.

The medication is taken orally, usually once daily, and the dose is adjusted based on the patient's response. Monitoring of liver and hematologic function is important during treatment.

Side effects may include nausea, diarrhea, hair loss, or elevated liver enzymes. In rare cases, severe reactions such as hepatotoxicity or pancytopenia may occur.

Leflunomide is not recommended for pregnant women or those planning to become pregnant, as well as patients with severe liver impairment or hypersensitivity to this medication.

General data about LEFLUNOMIDE WINTHROP 20mg

Substance:
leflunomide
Date of latest medicines list:
01-08-2024
Product code:
W55461001
Concentration:
20mg
Pharmaceutical form:
film-coated tablets
Quantity:
30
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Concentrations available for leflunomide

  • 100mg
  • 10mg
  • 20mg